VANGUARD GROUP INC 13D and 13G filings for iTeos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:08 pm Sale |
2023-12-29 | 13G | iTeos Therapeutics, Inc. ITOS |
VANGUARD GROUP INC | 1,490,942 4.170% |
-328,088 (-18.04%) |
Filing |
| 2023-02-09 11:22 am Purchase |
2022-12-30 | 13G | iTeos Therapeutics, Inc. ITOS |
VANGUARD GROUP INC | 1,819,030 5.110% |
1,819,030 (New Position) |
Filing |